J&J’s Vaccine Rollout a Shot in the Arm for These Biotech ETFs

Biotech ETFs are climbing again on Monday, as the the CDC approved Johnson & Johnson’s coronavirus vaccine for emergency use this past weekend. The Centers for Disease Control and Prevention advisory panel voted unanimously Sunday to recommend the use of Johnson & Johnson’s one-shot...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.